Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Waverley Pharma, Inc. (TSE:WAVE)
:WAVE
Holding TSE:WAVE?
Track your performance easily
WAVE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.04
Previous CloseN/A
VolumeN/A
Average Volume (3M)13.31K
Market Cap
C$540.00K
Enterprise ValueC$2.99M
Total Cash (Recent Filing)$100.00
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.59
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding54,000,000
10 Day Avg. Volume1,950
30 Day Avg. Volume13,310
Standard Deviation0.39
R-Squared0.04
Alpha0.00811
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.59
Price to Cash Flow (P/CF)2.90
P/FCF Ratio1.50
Enterprise Value/Market Cap5.54
Enterprise Value/Revenue42.05
Enterprise Value/Gross Profit37.49
Enterprise Value/Ebitda-1.59
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Waverley Pharma News
PremiumCompany Announcements
Waverley Pharma Expands with Strategic US Pharmacy Acquisition
PremiumCompany Announcements
Waverley Pharma Welcomes New DirectorWAVE FAQ
What was Waverley Pharma, Inc.’s price range in the past 12 months?
Waverley Pharma, Inc. lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
What is Waverley Pharma, Inc.’s market cap?
Waverley Pharma, Inc.’s market cap is C$540.00K.
When is Waverley Pharma, Inc.’s upcoming earnings report date?
Waverley Pharma, Inc.’s upcoming earnings report date is Apr 24, 2025 which is in 95 days.
How were Waverley Pharma, Inc.’s earnings last quarter?
Waverley Pharma, Inc. released its earnings results on Aug 23, 2024. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.006.
Is Waverley Pharma, Inc. overvalued?
According to Wall Street analysts Waverley Pharma, Inc.’s price is currently Undervalued.
Does Waverley Pharma, Inc. pay dividends?
Waverley Pharma, Inc. does not currently pay dividends.
What is Waverley Pharma, Inc.’s EPS estimate?
Waverley Pharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Waverley Pharma, Inc. have?
Waverley Pharma, Inc. has 54,000,000 shares outstanding.
What happened to Waverley Pharma, Inc.’s price movement after its last earnings report?
Waverley Pharma, Inc. reported an EPS of -C$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Waverley Pharma, Inc.?
Currently, no hedge funds are holding shares in TSE:WAVE
---
Company Description
Waverley Pharma, Inc.
Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide. It is also developing WAV-101 and WAV-102 products for the treatment of cancer. Geographically, it derives revenue from the United Kingdom.
---
Technical Analysis
---